BACKGROUND: Depression and adherence to antidepressant treatment are important clinical concerns in diabetes care. While patient-provider communication patterns have been associated with adherence for cardiometabolic medications, it is unknown whether interpersonal aspects of care impact antidepressant medication adherence. OBJECTIVE: To determine whether shared decision-making, patient-provider trust, or communication are associated with early stage and ongoing antidepressant adherence. DESIGN: Observational new prescription cohort study. SETTING:Kaiser Permanente Northern California. PATIENTS: One thousand five hundred twenty-three adults with type 2 diabetes who completed a survey in 2006 and received a new antidepressant prescription during 2006-2010. MEASUREMENTS: Exposures included items based on the Trust in Physicians and Interpersonal Processes of Care instruments and the Consumer Assessment of Healthcare Providers and Systems (CAHPS) communication scale. Measures of adherence were estimated using validated methods with physician prescribing and pharmacy dispensing data: primary non-adherence (medication never dispensed), early non-persistence (dispensed once, never refilled), and new prescription medication gap (NPMG; proportion of time without medication during 12 months after initial prescription). RESULTS: After adjusting for potential confounders, patients' perceived lack of shared decision-making was significantly associated with primary non-adherence (RR = 2.42, p < 0.05), early non-persistence (RR = 1.34, p < 0.01) and NPMG (estimated 5% greater gap in medication supply, p < 0.01). Less trust in provider was significantly associated with early non-persistence (RRs 1.22-1.25, ps < 0.05) and NPMG (estimated NPMG differences 5-8%, ps < 0.01). LIMITATIONS: All patients were insured and had consistent access to and quality of care. CONCLUSIONS: Patients' perceptions of their relationships with providers, including lack of shared decision-making or trust, demonstrated strong associations with antidepressant non-adherence. Further research should explore whether interventions for healthcare providers and systems that foster shared decision-making and trust might also improve medication adherence.
RCT Entities:
BACKGROUND:Depression and adherence to antidepressant treatment are important clinical concerns in diabetes care. While patient-provider communication patterns have been associated with adherence for cardiometabolic medications, it is unknown whether interpersonal aspects of care impact antidepressant medication adherence. OBJECTIVE: To determine whether shared decision-making, patient-provider trust, or communication are associated with early stage and ongoing antidepressant adherence. DESIGN: Observational new prescription cohort study. SETTING: Kaiser Permanente Northern California. PATIENTS: One thousand five hundred twenty-three adults with type 2 diabetes who completed a survey in 2006 and received a new antidepressant prescription during 2006-2010. MEASUREMENTS: Exposures included items based on the Trust in Physicians and Interpersonal Processes of Care instruments and the Consumer Assessment of Healthcare Providers and Systems (CAHPS) communication scale. Measures of adherence were estimated using validated methods with physician prescribing and pharmacy dispensing data: primary non-adherence (medication never dispensed), early non-persistence (dispensed once, never refilled), and new prescription medication gap (NPMG; proportion of time without medication during 12 months after initial prescription). RESULTS: After adjusting for potential confounders, patients' perceived lack of shared decision-making was significantly associated with primary non-adherence (RR = 2.42, p < 0.05), early non-persistence (RR = 1.34, p < 0.01) and NPMG (estimated 5% greater gap in medication supply, p < 0.01). Less trust in provider was significantly associated with early non-persistence (RRs 1.22-1.25, ps < 0.05) and NPMG (estimated NPMG differences 5-8%, ps < 0.01). LIMITATIONS: All patients were insured and had consistent access to and quality of care. CONCLUSIONS:Patients' perceptions of their relationships with providers, including lack of shared decision-making or trust, demonstrated strong associations with antidepressant non-adherence. Further research should explore whether interventions for healthcare providers and systems that foster shared decision-making and trust might also improve medication adherence.
Authors: Wayne J Katon; Carolyn Rutter; Greg Simon; Elizabeth H B Lin; Evette Ludman; Paul Ciechanowski; Leslie Kinder; Bessie Young; Michael Von Korff Journal: Diabetes Care Date: 2005-11 Impact factor: 19.112
Authors: Wayne J Katon; Gregory Simon; Joan Russo; Michael Von Korff; Elizabeth H B Lin; Evette Ludman; Paul Ciechanowski; Terry Bush Journal: Med Care Date: 2004-12 Impact factor: 2.983
Authors: Anita L Stewart; Anna M Nápoles-Springer; Steven E Gregorich; Jasmine Santoyo-Olsson Journal: Health Serv Res Date: 2007-06 Impact factor: 3.402
Authors: Audrey L Jones; Stefan G Kertesz; Leslie R M Hausmann; Maria K Mor; Ying Suo; Warren B P Pettey; James H Schaefer; Adi V Gundlapalli; Adam J Gordon Journal: J Subst Abuse Treat Date: 2020-02-29
Authors: Audrey L Jones; Maria K Mor; Gretchen L Haas; Adam J Gordon; John P Cashy; James H Schaefer; Leslie R M Hausmann Journal: J Gen Intern Med Date: 2018-06-08 Impact factor: 5.128
Authors: Richard O White; Rosette J Chakkalakal; Caroline A Presley; Aihua Bian; Jonathan S Schildcrout; Kenneth A Wallston; Shari Barto; Sunil Kripalani; Russell Rothman Journal: J Health Commun Date: 2016-09-23
Authors: Laura M Curtis; Rebecca J Mullen; Allison Russell; Aimee Fata; Stacy C Bailey; Gregory Makoul; Michael S Wolf Journal: Patient Educ Couns Date: 2016-07-02
Authors: Courtney R Lyles; Hilary K Seligman; Melissa M Parker; Howard H Moffet; Nancy Adler; Dean Schillinger; John D Piette; Andrew J Karter Journal: Health Serv Res Date: 2015-08-09 Impact factor: 3.402